Evoke® SCS System
FDA premarket approval P190002/S024 · decided 2024-02-29
Approval details
- PMA number
- P190002
- Supplement
- S024
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Evoke® SCS System
- Generic name
- Stimulator, spinal-cord, totally implanted for pain relief
- Applicant
- Saluda Medical Pty, Ltd.
- Date received
- 2024-01-31
- Decision date
- 2024-02-29
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- LGW
- Advisory committee
- Neurology
- Expedited review
- No
- Location
- Atarmon
- Statement
- the expansion of an existing clean room to support increased manufacturing capacity of the contract manufacturer for lead and lead accessories for the Evoke SCS System
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.